Paper
A New Oral Hypoglycemic Agent: l-Methyl-4-(3-methyl-5-isoxazolyl)pyridinium Chloride
Published Oct 1, 1968 · S. J. Riggi, D. Blickens, C. Boshart
Diabetes
Q1 SJR score
10
Citations
0
Influential Citations
Abstract
Oral administration of l-methyl-4-(3-methyl-5-isoxazolyl). pyridinium chloride (I) significantly decreased blood glucose concentration in cockerels, guinea pigs, normal mice and alloxan-hyperglycemic mice and rats. Alloxanized mice were most sensitive to the hypoglycemic action of I. These data indicate that I is an oral hypoglycemic agent in several species of experimental animals both in normo- and hyperglycemic states.
Study Snapshot
L-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride effectively decreases blood glucose levels in various species of experimental animals, both in normo- and hyperglycemic states.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···